103 related articles for article (PubMed ID: 519873)
1. Metoclopramide induced growth hormone release in hypogonadal males.
Cohen HN; Hay ID; Beastall GH; Thomson JA
Clin Endocrinol (Oxf); 1979 Jul; 11(1):95-7. PubMed ID: 519873
[TBL] [Abstract][Full Text] [Related]
2. Metoclopramide stimulation: a test of growth hormone reserve in adolescent males.
Cohen HN; Hay ID; Thomson JA; Logue F; Ratcliffe WA; Beastall GH
Clin Endocrinol (Oxf); 1979 Jul; 11(1):89-93. PubMed ID: 117953
[TBL] [Abstract][Full Text] [Related]
3. The prolactin response to metoclopramide in growth hormone deficient adolescent males.
Cohen HN; Beastall GH; Fyffe JA; Fitzgerald V; Thomson JA
Clin Endocrinol (Oxf); 1980 Aug; 13(2):207-11. PubMed ID: 7002371
[TBL] [Abstract][Full Text] [Related]
4. Prolactin response to exercise, metoclopramide and other provacative agents in children.
Ijaiya K
Eur J Pediatr; 1980 Sep; 134(3):231-7. PubMed ID: 6775949
[TBL] [Abstract][Full Text] [Related]
5. The effects of arginine, insulin and metoclopramide on growth hormone, prolactin and cortisol release in children.
Ijaiya K; Roth B; Schwenk A
Clin Endocrinol (Oxf); 1980 Jun; 12(6):589-94. PubMed ID: 6994940
[TBL] [Abstract][Full Text] [Related]
6. Androgen-dependent somatotroph function in a hypogonadal adolescent male: evidence for control of exogenous androgens on growth hormone release.
Mauras N; Blizzard RM; Rogol AD
Metabolism; 1989 Mar; 38(3):286-9. PubMed ID: 2493123
[TBL] [Abstract][Full Text] [Related]
7. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
8. Different effects of metoclopramide and domperidone on GH release in type I male diabetics.
Volpi R; Coiro V; Castelli A; Cappagli M; Muzzetto P; Sciarra A; Chiodera P
Horm Metab Res; 1984 Dec; 16 Suppl 1():131-3. PubMed ID: 6532934
[TBL] [Abstract][Full Text] [Related]
9. The metoclopramide test: a useful tool with the luteinizing hormone-releasing hormone test in distinguishing between constitutional delay of puberty and hypogonadotropic hypogonadism.
Lanes R; Palacios A; Avendano E; Moncada G; Chique G
Fertil Steril; 1989 Jul; 52(1):55-9. PubMed ID: 2663550
[TBL] [Abstract][Full Text] [Related]
10. Comparison of metoclopramide with other dynamic tests of prolactin secretion.
Sowers JR; McCallum RW; Hershman JM; Carlson HE; Sturdevant RA; Meyer N
J Clin Endocrinol Metab; 1976 Sep; 43(3):679-81. PubMed ID: 821965
[TBL] [Abstract][Full Text] [Related]
11. Effect of metoclopramide on serum growth hormone levels in cirrhotic men.
Volpi R; Coiro V; Salvi M; Pelosi G; Mancini P; Chiodera P
J Endocrinol Invest; 1983 Apr; 6(2):101-5. PubMed ID: 6863846
[TBL] [Abstract][Full Text] [Related]
12. Effects of metoclopramide on the growth hormone response to galanin in normal man.
Giustina A; Bussi AR; Doga M; Licini M; Schettino M; Wehrenberg WB
Horm Metab Res; 1993 Sep; 25(9):489-92. PubMed ID: 7693566
[TBL] [Abstract][Full Text] [Related]
13. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
[TBL] [Abstract][Full Text] [Related]
14. Prolactin response to metoclopramide does not distinguish patients with hypogonadotrophic hypogonadism from delayed puberty.
Cristiano AM; Munabi A; el Sabbagh H; Cassorla F; Sherins RJ
Clin Endocrinol (Oxf); 1988 Jan; 28(1):75-82. PubMed ID: 3168303
[TBL] [Abstract][Full Text] [Related]
15. Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with metoclopramide.
Arce V; Lima L; Lois N; Rodríguez A; Díaz MJ; Tresguerres JA; Devesa J
Neuroendocrinology; 1991 Feb; 53(2):143-9. PubMed ID: 1673022
[TBL] [Abstract][Full Text] [Related]
16. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone response to metoclopramide [proceedings].
Cohen HN; Hay ID; Thomson JA; Auchterlonie IA; Beastall GH
J Endocrinol; 1979 Oct; 83(1):49P-50P. PubMed ID: 521724
[No Abstract] [Full Text] [Related]
18. [Effect of metoclopramide on growth hormone (GH) release induced with ACTH].
Bizzarro A; Florio A; Varelli G; Cipolletta L; Iacono G
Boll Soc Ital Biol Sper; 1978 Sep; 54(17):1576-80. PubMed ID: 219871
[TBL] [Abstract][Full Text] [Related]
19. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
20. The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.
Del Rio G; Carani C; Velardo A; Procopio M; Zizzo G; Savio P; Mantovani R; Marrama P; Ghigo E
J Endocrinol Invest; 1996 Sep; 19(8):505-10. PubMed ID: 8905472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
